 | • レポートコード：QFJ1-5894 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、非オピオイド疼痛治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療大麻治療、カプサイシン由来治療、メントール含有治療、オメガ3脂肪酸含有治療、ボツリヌス毒素）、用途別市場規模（整形外科・筋骨格痛、神経因性疼痛、癌性疼痛、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・非オピオイド疼痛治療の市場動向 ・企業の競争状況、市場シェア ・非オピオイド疼痛治療の種類別市場規模と予測2016-2027（医療大麻治療、カプサイシン由来治療、メントール含有治療、オメガ3脂肪酸含有治療、ボツリヌス毒素） ・非オピオイド疼痛治療の用途別市場規模と予測2016-2027（整形外科・筋骨格痛、神経因性疼痛、癌性疼痛、その他） ・非オピオイド疼痛治療の北米市場規模2016-2027（アメリカ、カナダ） ・非オピオイド疼痛治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・非オピオイド疼痛治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・非オピオイド疼痛治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・非オピオイド疼痛治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan PLC、Canopy Growth、Medical Marijuana Inc.、Panag Pharma Inc.、Tilray、Aphria Inc.、Bedrocan、Cara Therapeutics、Centrexion Therapeutics、CHT Medical、Cronos Group、GW Pharmaceuticals、Medropharm Gmbh、US Worldmeds LLC） ・結論 |
Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals.
With growing concerns about the addictive nature of opioid painkillers, more and more companies are working to develop effective but not addictive therapies. The interest and demand for Non-Opioid has increased significantly.
Market Analysis and Insights: Global Non-Opioid Pain Treatment Market
The global Non-Opioid Pain Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-Opioid Pain Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-Opioid Pain Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-Opioid Pain Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-Opioid Pain Treatment market.
Global Non-Opioid Pain Treatment Scope and Market Size
Non-Opioid Pain Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Opioid Pain Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medical Cannabis Treatment
Capsaicin-derived Treatment
Menthol-containing Treatment
Omega 3 fatty acid-containing Treatment
Botulinum Toxins
Segment by Application
Orthopaedic and Musculoskeletal Pain
Neuropathic Pain
Cancer Pain
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan PLC
Canopy Growth
Medical Marijuana Inc.
Panag Pharma Inc.
Tilray
Aphria Inc.
Bedrocan
Cara Therapeutics
Centrexion Therapeutics
CHT Medical
Cronos Group
GW Pharmaceuticals
Medropharm Gmbh
US Worldmeds LLC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medical Cannabis Treatment
1.2.3 Capsaicin-derived Treatment
1.2.4 Menthol-containing Treatment
1.2.5 Omega 3 fatty acid-containing Treatment
1.2.6 Botulinum Toxins
1.3 Market by Application
1.3.1 Global Non-Opioid Pain Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Orthopaedic and Musculoskeletal Pain
1.3.3 Neuropathic Pain
1.3.4 Cancer Pain
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-Opioid Pain Treatment Market Perspective (2016-2027)
2.2 Non-Opioid Pain Treatment Growth Trends by Regions
2.2.1 Non-Opioid Pain Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-Opioid Pain Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Non-Opioid Pain Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Non-Opioid Pain Treatment Industry Dynamic
2.3.1 Non-Opioid Pain Treatment Market Trends
2.3.2 Non-Opioid Pain Treatment Market Drivers
2.3.3 Non-Opioid Pain Treatment Market Challenges
2.3.4 Non-Opioid Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Opioid Pain Treatment Players by Revenue
3.1.1 Global Top Non-Opioid Pain Treatment Players by Revenue (2016-2021)
3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-Opioid Pain Treatment Revenue
3.4 Global Non-Opioid Pain Treatment Market Concentration Ratio
3.4.1 Global Non-Opioid Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Opioid Pain Treatment Revenue in 2020
3.5 Non-Opioid Pain Treatment Key Players Head office and Area Served
3.6 Key Players Non-Opioid Pain Treatment Product Solution and Service
3.7 Date of Enter into Non-Opioid Pain Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Opioid Pain Treatment Breakdown Data by Type
4.1 Global Non-Opioid Pain Treatment Historic Market Size by Type (2016-2021)
4.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2022-2027)
5 Non-Opioid Pain Treatment Breakdown Data by Application
5.1 Global Non-Opioid Pain Treatment Historic Market Size by Application (2016-2021)
5.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Non-Opioid Pain Treatment Market Size (2016-2027)
6.2 North America Non-Opioid Pain Treatment Market Size by Type
6.2.1 North America Non-Opioid Pain Treatment Market Size by Type (2016-2021)
6.2.2 North America Non-Opioid Pain Treatment Market Size by Type (2022-2027)
6.2.3 North America Non-Opioid Pain Treatment Market Size by Type (2016-2027)
6.3 North America Non-Opioid Pain Treatment Market Size by Application
6.3.1 North America Non-Opioid Pain Treatment Market Size by Application (2016-2021)
6.3.2 North America Non-Opioid Pain Treatment Market Size by Application (2022-2027)
6.3.3 North America Non-Opioid Pain Treatment Market Size by Application (2016-2027)
6.4 North America Non-Opioid Pain Treatment Market Size by Country
6.4.1 North America Non-Opioid Pain Treatment Market Size by Country (2016-2021)
6.4.2 North America Non-Opioid Pain Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Non-Opioid Pain Treatment Market Size (2016-2027)
7.2 Europe Non-Opioid Pain Treatment Market Size by Type
7.2.1 Europe Non-Opioid Pain Treatment Market Size by Type (2016-2021)
7.2.2 Europe Non-Opioid Pain Treatment Market Size by Type (2022-2027)
7.2.3 Europe Non-Opioid Pain Treatment Market Size by Type (2016-2027)
7.3 Europe Non-Opioid Pain Treatment Market Size by Application
7.3.1 Europe Non-Opioid Pain Treatment Market Size by Application (2016-2021)
7.3.2 Europe Non-Opioid Pain Treatment Market Size by Application (2022-2027)
7.3.3 Europe Non-Opioid Pain Treatment Market Size by Application (2016-2027)
7.4 Europe Non-Opioid Pain Treatment Market Size by Country
7.4.1 Europe Non-Opioid Pain Treatment Market Size by Country (2016-2021)
7.4.2 Europe Non-Opioid Pain Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Non-Opioid Pain Treatment Market Size (2016-2027)
8.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type
8.2.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application
8.3.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region
8.4.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-Opioid Pain Treatment Market Size (2016-2027)
9.2 Latin America Non-Opioid Pain Treatment Market Size by Type
9.2.1 Latin America Non-Opioid Pain Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Non-Opioid Pain Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Non-Opioid Pain Treatment Market Size by Type (2016-2027)
9.3 Latin America Non-Opioid Pain Treatment Market Size by Application
9.3.1 Latin America Non-Opioid Pain Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Non-Opioid Pain Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Non-Opioid Pain Treatment Market Size by Application (2016-2027)
9.4 Latin America Non-Opioid Pain Treatment Market Size by Country
9.4.1 Latin America Non-Opioid Pain Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Non-Opioid Pain Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Opioid Pain Treatment Market Size (2016-2027)
10.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type
10.2.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application
10.3.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country
10.4.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan PLC
11.1.1 Allergan PLC Company Details
11.1.2 Allergan PLC Business Overview
11.1.3 Allergan PLC Non-Opioid Pain Treatment Introduction
11.1.4 Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.1.5 Allergan PLC Recent Development
11.2 Canopy Growth
11.2.1 Canopy Growth Company Details
11.2.2 Canopy Growth Business Overview
11.2.3 Canopy Growth Non-Opioid Pain Treatment Introduction
11.2.4 Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.2.5 Canopy Growth Recent Development
11.3 Medical Marijuana Inc.
11.3.1 Medical Marijuana Inc. Company Details
11.3.2 Medical Marijuana Inc. Business Overview
11.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Introduction
11.3.4 Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.3.5 Medical Marijuana Inc. Recent Development
11.4 Panag Pharma Inc.
11.4.1 Panag Pharma Inc. Company Details
11.4.2 Panag Pharma Inc. Business Overview
11.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Introduction
11.4.4 Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.4.5 Panag Pharma Inc. Recent Development
11.5 Tilray
11.5.1 Tilray Company Details
11.5.2 Tilray Business Overview
11.5.3 Tilray Non-Opioid Pain Treatment Introduction
11.5.4 Tilray Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.5.5 Tilray Recent Development
11.6 Aphria Inc.
11.6.1 Aphria Inc. Company Details
11.6.2 Aphria Inc. Business Overview
11.6.3 Aphria Inc. Non-Opioid Pain Treatment Introduction
11.6.4 Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.6.5 Aphria Inc. Recent Development
11.7 Bedrocan
11.7.1 Bedrocan Company Details
11.7.2 Bedrocan Business Overview
11.7.3 Bedrocan Non-Opioid Pain Treatment Introduction
11.7.4 Bedrocan Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.7.5 Bedrocan Recent Development
11.8 Cara Therapeutics
11.8.1 Cara Therapeutics Company Details
11.8.2 Cara Therapeutics Business Overview
11.8.3 Cara Therapeutics Non-Opioid Pain Treatment Introduction
11.8.4 Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.8.5 Cara Therapeutics Recent Development
11.9 Centrexion Therapeutics
11.9.1 Centrexion Therapeutics Company Details
11.9.2 Centrexion Therapeutics Business Overview
11.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Introduction
11.9.4 Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.9.5 Centrexion Therapeutics Recent Development
11.10 CHT Medical
11.10.1 CHT Medical Company Details
11.10.2 CHT Medical Business Overview
11.10.3 CHT Medical Non-Opioid Pain Treatment Introduction
11.10.4 CHT Medical Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.10.5 CHT Medical Recent Development
11.11 Cronos Group
11.11.1 Cronos Group Company Details
11.11.2 Cronos Group Business Overview
11.11.3 Cronos Group Non-Opioid Pain Treatment Introduction
11.11.4 Cronos Group Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.11.5 Cronos Group Recent Development
11.12 GW Pharmaceuticals
11.12.1 GW Pharmaceuticals Company Details
11.12.2 GW Pharmaceuticals Business Overview
11.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Introduction
11.12.4 GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.12.5 GW Pharmaceuticals Recent Development
11.13 Medropharm Gmbh
11.13.1 Medropharm Gmbh Company Details
11.13.2 Medropharm Gmbh Business Overview
11.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Introduction
11.13.4 Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.13.5 Medropharm Gmbh Recent Development
11.14 US Worldmeds LLC
11.14.1 US Worldmeds LLC Company Details
11.14.2 US Worldmeds LLC Business Overview
11.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Introduction
11.14.4 US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2016-2021)
11.14.5 US Worldmeds LLC Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Non-Opioid Pain Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medical Cannabis Treatment
Table 3. Key Players of Capsaicin-derived Treatment
Table 4. Key Players of Menthol-containing Treatment
Table 5. Key Players of Omega 3 fatty acid-containing Treatment
Table 6. Key Players of Botulinum Toxins
Table 7. Global Non-Opioid Pain Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Non-Opioid Pain Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Non-Opioid Pain Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Non-Opioid Pain Treatment Market Share by Regions (2016-2021)
Table 11. Global Non-Opioid Pain Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Non-Opioid Pain Treatment Market Share by Regions (2022-2027)
Table 13. Non-Opioid Pain Treatment Market Trends
Table 14. Non-Opioid Pain Treatment Market Drivers
Table 15. Non-Opioid Pain Treatment Market Challenges
Table 16. Non-Opioid Pain Treatment Market Restraints
Table 17. Global Non-Opioid Pain Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Non-Opioid Pain Treatment Market Share by Players (2016-2021)
Table 19. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Opioid Pain Treatment as of 2020)
Table 20. Ranking of Global Top Non-Opioid Pain Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Non-Opioid Pain Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Non-Opioid Pain Treatment Product Solution and Service
Table 24. Date of Enter into Non-Opioid Pain Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Non-Opioid Pain Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Non-Opioid Pain Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Non-Opioid Pain Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Non-Opioid Pain Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Non-Opioid Pain Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Non-Opioid Pain Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Non-Opioid Pain Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Non-Opioid Pain Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Non-Opioid Pain Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Allergan PLC Company Details
Table 65. Allergan PLC Business Overview
Table 66. Allergan PLC Non-Opioid Pain Treatment Product
Table 67. Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 68. Allergan PLC Recent Development
Table 69. Canopy Growth Company Details
Table 70. Canopy Growth Business Overview
Table 71. Canopy Growth Non-Opioid Pain Treatment Product
Table 72. Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 73. Canopy Growth Recent Development
Table 74. Medical Marijuana Inc. Company Details
Table 75. Medical Marijuana Inc. Business Overview
Table 76. Medical Marijuana Inc. Non-Opioid Pain Treatment Product
Table 77. Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 78. Medical Marijuana Inc. Recent Development
Table 79. Panag Pharma Inc. Company Details
Table 80. Panag Pharma Inc. Business Overview
Table 81. Panag Pharma Inc. Non-Opioid Pain Treatment Product
Table 82. Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 83. Panag Pharma Inc. Recent Development
Table 84. Tilray Company Details
Table 85. Tilray Business Overview
Table 86. Tilray Non-Opioid Pain Treatment Product
Table 87. Tilray Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 88. Tilray Recent Development
Table 89. Aphria Inc. Company Details
Table 90. Aphria Inc. Business Overview
Table 91. Aphria Inc. Non-Opioid Pain Treatment Product
Table 92. Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 93. Aphria Inc. Recent Development
Table 94. Bedrocan Company Details
Table 95. Bedrocan Business Overview
Table 96. Bedrocan Non-Opioid Pain Treatment Product
Table 97. Bedrocan Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 98. Bedrocan Recent Development
Table 99. Cara Therapeutics Company Details
Table 100. Cara Therapeutics Business Overview
Table 101. Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 102. Cara Therapeutics Recent Development
Table 103. Centrexion Therapeutics Company Details
Table 104. Centrexion Therapeutics Business Overview
Table 105. Centrexion Therapeutics Non-Opioid Pain Treatment Product
Table 106. Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 107. Centrexion Therapeutics Recent Development
Table 108. CHT Medical Company Details
Table 109. CHT Medical Business Overview
Table 110. CHT Medical Non-Opioid Pain Treatment Product
Table 111. CHT Medical Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 112. CHT Medical Recent Development
Table 113. Cronos Group Company Details
Table 114. Cronos Group Business Overview
Table 115. Cronos Group Non-Opioid Pain Treatment Product
Table 116. Cronos Group Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 117. Cronos Group Recent Development
Table 118. GW Pharmaceuticals Company Details
Table 119. GW Pharmaceuticals Business Overview
Table 120. GW Pharmaceuticals Non-Opioid Pain Treatment Product
Table 121. GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 122. GW Pharmaceuticals Recent Development
Table 123. Medropharm Gmbh Company Details
Table 124. Medropharm Gmbh Business Overview
Table 125. Medropharm Gmbh Non-Opioid Pain Treatment Product
Table 126. Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 127. Medropharm Gmbh Recent Development
Table 128. US Worldmeds LLC Company Details
Table 129. US Worldmeds LLC Business Overview
Table 130. US Worldmeds LLC Non-Opioid Pain Treatment Product
Table 131. US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2016-2021) & (US$ Million)
Table 132. US Worldmeds LLC Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Opioid Pain Treatment Market Share by Type: 2020 VS 2027
Figure 2. Medical Cannabis Treatment Features
Figure 3. Capsaicin-derived Treatment Features
Figure 4. Menthol-containing Treatment Features
Figure 5. Omega 3 fatty acid-containing Treatment Features
Figure 6. Botulinum Toxins Features
Figure 7. Global Non-Opioid Pain Treatment Market Share by Application: 2020 VS 2027
Figure 8. Orthopaedic and Musculoskeletal Pain Case Studies
Figure 9. Neuropathic Pain Case Studies
Figure 10. Cancer Pain Case Studies
Figure 11. Others Case Studies
Figure 12. Non-Opioid Pain Treatment Report Years Considered
Figure 13. Global Non-Opioid Pain Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Non-Opioid Pain Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Non-Opioid Pain Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Non-Opioid Pain Treatment Market Share by Regions (2022-2027)
Figure 17. Global Non-Opioid Pain Treatment Market Share by Players in 2020
Figure 18. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Opioid Pain Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Non-Opioid Pain Treatment Revenue in 2020
Figure 20. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Non-Opioid Pain Treatment Market Share by Type (2016-2027)
Figure 24. North America Non-Opioid Pain Treatment Market Share by Application (2016-2027)
Figure 25. North America Non-Opioid Pain Treatment Market Share by Country (2016-2027)
Figure 26. United States Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Non-Opioid Pain Treatment Market Share by Type (2016-2027)
Figure 30. Europe Non-Opioid Pain Treatment Market Share by Application (2016-2027)
Figure 31. Europe Non-Opioid Pain Treatment Market Share by Country (2016-2027)
Figure 32. Germany Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Non-Opioid Pain Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Non-Opioid Pain Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Non-Opioid Pain Treatment Market Share by Region (2016-2027)
Figure 42. China Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Non-Opioid Pain Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Non-Opioid Pain Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Non-Opioid Pain Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Non-Opioid Pain Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Non-Opioid Pain Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Non-Opioid Pain Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Non-Opioid Pain Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Allergan PLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 62. Canopy Growth Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 63. Medical Marijuana Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 64. Panag Pharma Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 65. Tilray Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 66. Aphria Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 67. Bedrocan Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 68. Cara Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 69. Centrexion Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 70. CHT Medical Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 71. Cronos Group Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 72. GW Pharmaceuticals Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 73. Medropharm Gmbh Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 74. US Worldmeds LLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界のオピオイド離脱治療市場規模・現状・予測（2021年-2027年） In some cases, usage of opioids causes addiction, and opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment…- 世界のボツリヌス菌感染症治療市場規模・現状・予測（2021年-2027年） Clostridium botulinum infections are caused by clostridium botulinum, a gram-positive, rod-shaped bacterium which produces an extremely lethal substance that is botulism neurotoxin. Market Analysis and Insights: Global Clostridium Botulinum Infection Treatment Market The global Clostridium Botulinum…
- 世界のオピオイド使用障害市場規模・現状・予測（2021年-2027年） An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress. Increase in opioid epidemic in the U.S. coupled with establishment of government poli…
- 世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年） Cervical dystonia/spasmodic torticollis is the involuntary muscular contraction of the neck, which leads to head twist. It is a rare neurological disorder that affects all age groups and most often it affects middle-aged people. Market Analysis and Insights: Global Cervical Dystonia Treatment Marke…
- 世界の咽後膿瘍治療市場規模・現状・予測（2021年-2027年） A retropharyngeal abscess is a serious infection, usually starts in the lymph nodes, characterised by collection of pus at the back of the throat. Retropharyngeal abscess typically occurs in children under the age of eight, sometimes it can also affect adults. The symptoms of retropharyngeal abscess…